Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Uveal Melanoma × Amplified Fragment Length Polymorphism Analysis × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 6 Lymphoma, Follicular 4 Lymphoma 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, Extranodal NK-T-Cell 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Hodgkin Disease 3 Burkitt Lymphoma 3 Waldenstrom Macroglobulinemia 2 Sezary Syndrome 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Myelodysplastic Syndromes 2 Mycosis Fungoides 2 Multiple Myeloma 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Accelerated Phase 2 Immunoblastic Lymphadenopathy 2 Congenital Abnormalities 2 Breast Neoplasms 2 Thrombocytopenia 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1

Interventions

Ipilimumab 5 pembrolizumab 4 Nivolumab 4 Dacarbazine 4 CTLA-4 Antigen 3 aflibercept 2 Temozolomide 2 Ranibizumab 2 Radiosurgery 2 Paclitaxel 2 Lenalidomide 2 Cyclophosphamide 2 Carboplatin 2 Bevacizumab 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 utomilumab 1 ulixertinib 1 trametinib 1 tebentafusp 1 sotrastaurin 1 sargramostim 1 relatlimab 1 poly ICLC 1 pasireotide 1 omipalisib 1 oblimersen 1 niraparib 1 lenvatinib 1 glembatumumab vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡